Abstract
Purpose
Craniopharyngiomas (CP) are benign tumours of the sellar region. Hypopituitarism, visual deficits, hypothalamic damage with consequent obesity and related increased cardiovascular risk, are complications due to the tumour itself or secondary to treatment strategy. We retrospectively correlated visual field status with clinical, neuroradiological, histopathological features and management strategy, in a single-centre cohort of patients with CP.
Methods
Thirty-four patients (16 M; median age 27.2 ± 21.8 yrs) with CP were included. We evaluated visual field status, assessed by means of standard automated perimetry and expressed as mean deviation (MD), at last follow-up visit (median 14 ± 11.7 yrs). MD has been correlated with clinical, radiological, histological data and treatment modalities.
Results
In univariate analysis worst eye MD was significantly associated with panhypopituitarism (p 0.010). In multivariable linear regression, panhypopituitarism (p 0.008), CP recurrence (p 0.020) and DI (p 0.004) were found to be the main independent predictors of a worse visual field outcome. When stratifying patients according to the degree of visual field impairment (MD < −12 dB Vs MD > −12 dB), the main independent predictors of worse visual field outcome were older age at diagnosis (p 0.010), CP histological subtype (p 0.004), invasiveness (p 0.04), CP recurrence (p 0.035), DI (p 0.002) and weight at last follow-up (p 0.012).
Conclusion
In CP patients the long-term ophthalmological impairment is frequent, especially at older age, and strictly related to tumour invasiveness and recurrence, and associated to pituitary disfunction and obesity.
References
A. Poretti, M.A. Grotzer, K. Ribi, E. Schönle, E. Boltshauser, Outcome of craniopharyngioma in children: long-term complications and quality of life. Dev. Med. Child. Neurol. (2004). https://doi.org/10.1017/s0012162204000374
C. Capatina, M. Vintila, I. Gherlan, A. Dumitraşcu, A. Caragheorgheopol, C. Procopiuc, V. Ciubotaru, C. Poiana, Craniopharyngioma—clinical and therapeutic outcome data in mixed cohort of adult and pediatric cases. Acta Endocrinol. (Buchar). (2018). https://doi.org/10.4183/aeb.2018.549
I. Chakrabarti, A.P. Amar, W. Couldwell, W.H. Weiss, Long-term neurological, visual, and endocrine outcomes following transnasal resection of craniopharyngioma. J. Neurosurg. (2005). https://doi.org/10.3171/jns.2005.102.4.0650
M.J. Wan, M. Zapotocky, E. Bouffet, U. Bartels, A.V. Kulkarni, J.M. Drake, Long-term visual outcomes of craniopharyngioma in children. J. Neurooncol. (2018). https://doi.org/10.1007/s11060-018-2762-3
I. Forchheimer, C.G. de Moraes, C.C. Teng, F. Folgar, C. Tello, R. Ritch, J.M. Liebmann, Baseline mean deviation and rates of visual field change in treated glaucoma patients. Eye Lond. 25, 626–632 (2011)
S. Cannavò, F. Marini, F. Trimarchi, Patients with craniopharyngiomas: therapeutical difficulties with growth hormone. J. Endocrinol. Invest 31, 56–60 (2008)
S. Kopparapu, A.M. Khalafallah, D. Botros, A.R. Carey, F.J. Rodriguez, D. Duan, N.R. Rowan, D. Mukherjee, Predictors of postoperative visual outcome after surgical intervention for craniopharyngiomas. World. Neurosurg. (2021). https://doi.org/10.1016/j.wneu.2021.01.044
F. Ferraù, F. Spagnolo, O.R., Cotta, L. Cannavò, A. Alibrandi, G. Russo, T. Aversa, F. Trimarchi, S. Cannavò, Visceral adiposity index as an indicator of cardiometabolic risk in patients treated for craniopharyngioma. Endocrine (2017). https://doi.org/10.1007/s12020-016-1196-y
P. Dogra, L. Bedatsova, J.J. Van Gompel, C. Giannini, D.M. Donegan, D. Erickson. Long-term outcomes in patients with adult-onset craniopharyngioma. Endocrine (2022). https://doi.org/10.1007/s12020-022-03134-4
R.R. Sharma, M.J. Chandy, S.D. Lad, Diencephalic syndrome of emaciation in an adult associated with a suprasellar craniopharyngioma: a case report. Br. J. Neurosurg. 4, 77–80 (1990)
M.A. Nuijts, N. Veldhuis, I. Stegeman, H.M. Van Santen, G.L. Porro, S.M. Imhof, A.Y.N. Schouten-van Meeteren, Visual functions in children with craniopharyngioma at diagnosis: A systematic review. PLoS. One. (2020). https://doi.org/10.1371/journal.pone.0240016
Author contributions
All authors contributed to the study conception and design. Material preparation, data collection and analysis were performed by S.G., G.O., O.R.C., R.C. The first draft of the manuscript was written by F.F., S.G., P.A., S.C. and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Ethics approval
This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of University of Messina (Italy).
Consent to participate
Informed consent was obtained from all individual participants included in the study.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Giovinazzo, S., Oliverio, G., Cotta, O.R. et al. Persistent severe visual field impairment is associated with obesity and tumour invasiveness, but not with pituitary dysfunction, in patients with craniopharyngioma. Endocrine 81, 50–53 (2023). https://doi.org/10.1007/s12020-023-03359-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-023-03359-x